Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Doglio

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Current Pediatric Reviews|January 28, 2022
Adenosine Blood Level: A Biomarker of White Matter Damage in Very Low Birth Weight InfantsMarina Colella, Isabella Panfoli, Matteo Doglio, et al.
Frontiers in Immunology|January 8, 2024
Lymphodepletion - an essential but undervalued part of the chimeric antigen receptor T-cell therapy cycleBenno Lickefett, Lulu Chu, Valentin Ortiz-Maldonado, et al.
European Journal of Immunology|June 3, 2021
Flow cytometry data mining by cytoChain identifies determinants of exhaustion and stemness in TCR-engineered T cellsFrancesco Manfredi, Danilo Abbati, Beatrice Claudia Cianciotti, et al.
Bone Marrow Transplantation|April 9, 2025
Less frequent complications following CAR T-cell therapies: hemophagocytic lymphohistiocytosis, graft-versus-host disease, thrombotic microangiopathy, coagulation disorders and secondary malignancies: best practice recommendations from the EBMT Practice Harmonization and Guidelines CommitteeGuillermo Ortí, Guillaume Dachy, Charlotte E Graham, et al.
Bone Marrow Transplantation|July 19, 2023
Dynamics of polyclonal immuno-reconstitution after allogeneic transplant with post-transplant cyclophosphamide and letermovirGiorgio Orofino, Elisabetta Xue, Matteo Doglio, et al.
Frontiers in Immunology|September 2, 2025
Biomarkers for an early diagnosis of immune effector cell associated-hemophagocytic syndromeEdoardo Campodonico, Piera Angelillo, Matteo Doglio, et al.
The Lancet. Oncology|April 3, 2025
Non-ICANS neurological complications after CAR T-cell therapies: recommendations from the EBMT Practice Harmonisation and Guidelines CommitteeCharlotte E Graham, Roser Velasco, Ana Alarcon Tomas, et al.
Haematologica|September 4, 2025
Impact of letermovir on Cytomegalovirus-specific T-cells reconstitution after allogeneic hematopoietic stem cell transplantation in the post-transplant cyclophosphamide eraElena Tassi, Giorgio Orofino, Valeria Beretta, et al.
Haematologica|August 21, 2020
Emapalumab treatment in an ADA-SCID patient with refractory hemophagocytic lymphohistiocytosis-related graft failure and disseminated bacillus Calmette-Guérin infectionFrancesca Tucci, Vera Gallo, Federica Barzaghi, et al.
The Journal of Rheumatology|November 17, 2015
Performance of Different Diagnostic Criteria for Familial Mediterranean Fever in Children with Periodic Fevers: Results from a Multicenter International RegistryErkan Demirkaya, Celal Saglam, Turker Turker, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Current Pediatric Reviews|January 28, 2022
Adenosine Blood Level: A Biomarker of White Matter Damage in Very Low Birth Weight InfantsMarina Colella, Isabella Panfoli, Matteo Doglio, et al.
Frontiers in Immunology|January 8, 2024
Lymphodepletion - an essential but undervalued part of the chimeric antigen receptor T-cell therapy cycleBenno Lickefett, Lulu Chu, Valentin Ortiz-Maldonado, et al.
European Journal of Immunology|June 3, 2021
Flow cytometry data mining by cytoChain identifies determinants of exhaustion and stemness in TCR-engineered T cellsFrancesco Manfredi, Danilo Abbati, Beatrice Claudia Cianciotti, et al.
Bone Marrow Transplantation|April 9, 2025
Less frequent complications following CAR T-cell therapies: hemophagocytic lymphohistiocytosis, graft-versus-host disease, thrombotic microangiopathy, coagulation disorders and secondary malignancies: best practice recommendations from the EBMT Practice Harmonization and Guidelines CommitteeGuillermo Ortí, Guillaume Dachy, Charlotte E Graham, et al.
Bone Marrow Transplantation|July 19, 2023
Dynamics of polyclonal immuno-reconstitution after allogeneic transplant with post-transplant cyclophosphamide and letermovirGiorgio Orofino, Elisabetta Xue, Matteo Doglio, et al.
Frontiers in Immunology|September 2, 2025
Biomarkers for an early diagnosis of immune effector cell associated-hemophagocytic syndromeEdoardo Campodonico, Piera Angelillo, Matteo Doglio, et al.
The Lancet. Oncology|April 3, 2025
Non-ICANS neurological complications after CAR T-cell therapies: recommendations from the EBMT Practice Harmonisation and Guidelines CommitteeCharlotte E Graham, Roser Velasco, Ana Alarcon Tomas, et al.
Haematologica|September 4, 2025
Impact of letermovir on Cytomegalovirus-specific T-cells reconstitution after allogeneic hematopoietic stem cell transplantation in the post-transplant cyclophosphamide eraElena Tassi, Giorgio Orofino, Valeria Beretta, et al.
Haematologica|August 21, 2020
Emapalumab treatment in an ADA-SCID patient with refractory hemophagocytic lymphohistiocytosis-related graft failure and disseminated bacillus Calmette-Guérin infectionFrancesca Tucci, Vera Gallo, Federica Barzaghi, et al.
The Journal of Rheumatology|November 17, 2015
Performance of Different Diagnostic Criteria for Familial Mediterranean Fever in Children with Periodic Fevers: Results from a Multicenter International RegistryErkan Demirkaya, Celal Saglam, Turker Turker, et al.
Pageof 3